Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Polartechnics makes debut in STI diagnostics market

This article was originally published in Clinica

Executive Summary

Diagnostics company Polartechnics is breaking into the global market for sexually-transmitted infection testing, after it clinched a deal for a modified version of its CerviScreen self-sampling device. Sydney, Australia-based Polartechnics has adapted the CervicScreen, originally designed for cervical screening purposes, so that the new device collects samples to test for STIs, including chlamydia, gonorrhoea and trichomoniasis. The company will make the STI self-sampling device available in Australia through Gribbles Pathology, a pathology services provider with a network of 43 labs across the continent. The product will be distributed in China and south-east Asia through retail pharmacies. Polartechnics added that it is also currently in talks to seal distribution deals for the product in Europe and the US.

You may also be interested in...

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts